Measuring potency for gene and cell therapies is not so clear-cut, and some companies have hit roadblocks in their submissions to regulatory agencies as a result. This webinar will look at ways to overcome that hurdle as well as challenges in relation...
Innovations in drug delivery never stop and constant progress continues way past the oral route with the development of implants, patches, syringes as well as solutions for transdermal, topical, and oral drug delivery systems that target diseases, provide...
Measuring potency for gene and cell therapies is not so clear-cut, and some companies have hit roadblocks in their submissions to regulatory agencies as a result. This webinar will look at ways to overcome that hurdle as well as challenges in relation...
Bioprocessing 4.0 is embodied in the tools that increase efficiency and help companies keep an edge in today’s competitive biopharma landscape. In this webinar we review approaches that use digitization to give companies the flexibility needed to adjust...
Significant research and development interest exists in developing less-invasive or non-invasive routes for the systemic delivery of biologics, including subcutaneous, transdermal, oral, inhalation, nasal and buccal routes. This webinar will look at the...
The pipeline of advanced therapy is expanding at a rate never seen before, with a number of cell and gene therapies now reaching the market. As a result, the services required to develop them are in more demand than ever.
Discussions around the manufacture of vaccines has never been more important. COVID-19 has brought to light how important having an efficient manufacturing process for vaccines is, as well as placing high demand on those providing capacity to the industry....
